Post-Surgery Dietary Adherence Program
Construction and empirical study of a dietary adherence intervention program for post-pancreatic surgery patients based on the behavior change wheel (BCW) framework
| Competitors | Pros | Cons | Starting price | Product similarity | Customer feedback |
|---|---|---|---|---|---|
AI-powered predictive analytics Comprehensive device integration Proven usage in surgical home hospital programs | Limited to specific device partnerships Requires multiple devices for comprehensive monitoring May have high implementation costs | — | 85% similar Both target post-surgical patients during recovery and aim to improve health outcomes through continuous monitoring and intervention. Biofourmis focuses on remote monitoring of post-operative patients at home, overlapping with the user's goal of supporting post-pancreatic surgery patients through structured adherence programs. | <UNKNOWN> | |
Significantly reduced postoperative complications (22.4%) Decreased average hospitalization time after surgery Improved medical services and patient satisfaction | Limited to WeChat platform ecosystem Requires medical staff training and adoption May have language barriers for international use | — | 85% similar WANHA directly addresses nutritional management and dietary adherence for post-surgical patients using a digital platform, closely mirroring the user's focus on dietary adherence in post-pancreatic surgery recovery. Both target patients and medical staff managing perioperative and post-operative nutritional needs. | <UNKNOWN> | |
Strong focus on digital health technologies Advanced monitoring capabilities Integration of smart systems | May not specifically focus on dietary adherence Limited behavioral change intervention capabilities | — | 80% similar Abbott's postoperative monitoring and management systems share the goal of supporting patient recovery after surgery through digital health tools, overlapping with the user's intervention program targeting post-surgical patients. Both address the broader challenge of managing patient health outcomes in the post-operative period. | <UNKNOWN> | |
Large patient volume (15,224 procedures) Established nationwide coverage Low in-hospital mortality rate (1.3%) | Limited core parameter availability (missing some of 55 core parameters) Lower minimally invasive surgery adoption (7.8%) Moderate preoperative chemotherapy usage (27.6%) | $14500 | 80% similar NSQIP specifically tracks outcomes for pancreatoduodenectomy (pancreatic surgery) patients, sharing the same surgical population as the user's project. Its focus on quality improvement and empirical outcome tracking in pancreatic surgery aligns with the user's empirical study component. | 4.2/5 | |
Seamless patient journey from pre-admission to post-discharge Significantly improved patient satisfaction Strengthened patient retention | Complex platform requiring significant investment May require extensive patient education | — | 80% similar The platform's remote guided care and treatment continuation features overlap with the user's goal of supporting post-surgical patients through structured interventions beyond the hospital setting. Both aim to extend care delivery to patients managing recovery outside of traditional clinical environments. | 4.2/5 | |
Substantial patient volume (3,558 procedures) Comprehensive data collection Established in German healthcare system | Higher in-hospital mortality rate (4.7%) Longest median length of stay (16.0 days) Highest reoperation rate (17.1%) | — | 80% similar Like NSQIP, the DGAV registry collects empirical data on pancreatic surgery outcomes including pancreatoduodenectomy, sharing the same surgical patient population as the user's project. Its focus on quality metrics and outcome documentation supports the same evidence-based improvement goals central to the user's empirical study. | <UNKNOWN> | |
Good patient volume (2,795 procedures) Highest minimally invasive surgery adoption (13.5%) Moderate reoperation rate (8.7%) | Moderate in-hospital mortality rate (3.6%) Low preoperative chemotherapy usage (7.0%) Longer median length of stay (12.0 days) | — | 80% similar The Dutch Pancreatic Cancer Audit focuses specifically on pancreatic surgery outcomes and quality improvement, directly overlapping with the user's target population of post-pancreatic surgery patients. Its empirical, registry-based approach to tracking patient outcomes mirrors the user's goal of conducting an evidence-based intervention study. | 4.2/5 | |
Predictable recurring revenue model Meets diverse patient needs Flexible care options | Limited to private healthcare market May exclude lower-income patients | — | 80% similar The tiered membership platform offers flexible, ongoing care management that partially overlaps with the user's goal of providing structured post-surgical support and adherence programs. Both address the need for continued patient engagement and care beyond the acute hospital stay. | <UNKNOWN> | |
Continuous monitoring capabilities Multiple vital sign tracking Proven integration with major platforms | Single device solution requiring additional devices for comprehensive monitoring Dependent on integration partners for full functionality May require frequent replacement | — | 75% similar VitalPatch supports continuous monitoring of post-surgical patients recovering at home, sharing the target audience of post-operative patients requiring ongoing health management. Its role in remote recovery monitoring complements the type of adherence tracking central to the user's dietary intervention program. | 4.2/5 | |
Established pharmaceutical company Strong presence in pain management Research-backed solutions | Limited behavioral intervention focus May not address dietary adherence specifically | — | 70% similar Eli Lilly's postoperative care solutions target the same post-surgical recovery phase as the user's program, addressing patient management after surgical procedures. Both operate in the post-operative care space, though the user's project focuses specifically on dietary behavior change rather than pharmaceutical management. | <UNKNOWN> |
View Files per page
1-10 of 20 competitors
Pros
AI-powered predictive analytics
Comprehensive device integration
Proven usage in surgical home hospital programs
Cons
Limited to specific device partnerships
Requires multiple devices for comprehensive monitoring
May have high implementation costs
Starting price: —
Product similarity: 85% Both target post-surgical patients during recovery and aim to improve health outcomes through continuous monitoring and intervention. Biofourmis focuses on remote monitoring of post-operative patients at home, overlapping with the user's goal of supporting post-pancreatic surgery patients through structured adherence programs.
Customer feedback: <UNKNOWN>
Pros
Significantly reduced postoperative complications (22.4%)
Decreased average hospitalization time after surgery
Improved medical services and patient satisfaction
Cons
Limited to WeChat platform ecosystem
Requires medical staff training and adoption
May have language barriers for international use
Starting price: —
Product similarity: 85% WANHA directly addresses nutritional management and dietary adherence for post-surgical patients using a digital platform, closely mirroring the user's focus on dietary adherence in post-pancreatic surgery recovery. Both target patients and medical staff managing perioperative and post-operative nutritional needs.
Customer feedback: <UNKNOWN>
Pros
Strong focus on digital health technologies
Advanced monitoring capabilities
Integration of smart systems
Cons
May not specifically focus on dietary adherence
Limited behavioral change intervention capabilities
Starting price: —
Product similarity: 80% Abbott's postoperative monitoring and management systems share the goal of supporting patient recovery after surgery through digital health tools, overlapping with the user's intervention program targeting post-surgical patients. Both address the broader challenge of managing patient health outcomes in the post-operative period.
Customer feedback: <UNKNOWN>
Pros
Large patient volume (15,224 procedures)
Established nationwide coverage
Low in-hospital mortality rate (1.3%)
Cons
Limited core parameter availability (missing some of 55 core parameters)
Lower minimally invasive surgery adoption (7.8%)
Moderate preoperative chemotherapy usage (27.6%)
Starting price: $14500
Product similarity: 80% NSQIP specifically tracks outcomes for pancreatoduodenectomy (pancreatic surgery) patients, sharing the same surgical population as the user's project. Its focus on quality improvement and empirical outcome tracking in pancreatic surgery aligns with the user's empirical study component.
Customer feedback: 4.2/5
Pros
Seamless patient journey from pre-admission to post-discharge
Significantly improved patient satisfaction
Strengthened patient retention
Cons
Complex platform requiring significant investment
May require extensive patient education
Starting price: —
Product similarity: 80% The platform's remote guided care and treatment continuation features overlap with the user's goal of supporting post-surgical patients through structured interventions beyond the hospital setting. Both aim to extend care delivery to patients managing recovery outside of traditional clinical environments.
Customer feedback: 4.2/5
Pros
Substantial patient volume (3,558 procedures)
Comprehensive data collection
Established in German healthcare system
Cons
Higher in-hospital mortality rate (4.7%)
Longest median length of stay (16.0 days)
Highest reoperation rate (17.1%)
Starting price: —
Product similarity: 80% Like NSQIP, the DGAV registry collects empirical data on pancreatic surgery outcomes including pancreatoduodenectomy, sharing the same surgical patient population as the user's project. Its focus on quality metrics and outcome documentation supports the same evidence-based improvement goals central to the user's empirical study.
Customer feedback: <UNKNOWN>
Pros
Good patient volume (2,795 procedures)
Highest minimally invasive surgery adoption (13.5%)
Moderate reoperation rate (8.7%)
Cons
Moderate in-hospital mortality rate (3.6%)
Low preoperative chemotherapy usage (7.0%)
Longer median length of stay (12.0 days)
Starting price: —
Product similarity: 80% The Dutch Pancreatic Cancer Audit focuses specifically on pancreatic surgery outcomes and quality improvement, directly overlapping with the user's target population of post-pancreatic surgery patients. Its empirical, registry-based approach to tracking patient outcomes mirrors the user's goal of conducting an evidence-based intervention study.
Customer feedback: 4.2/5
Pros
Predictable recurring revenue model
Meets diverse patient needs
Flexible care options
Cons
Limited to private healthcare market
May exclude lower-income patients
Starting price: —
Product similarity: 80% The tiered membership platform offers flexible, ongoing care management that partially overlaps with the user's goal of providing structured post-surgical support and adherence programs. Both address the need for continued patient engagement and care beyond the acute hospital stay.
Customer feedback: <UNKNOWN>
Pros
Continuous monitoring capabilities
Multiple vital sign tracking
Proven integration with major platforms
Cons
Single device solution requiring additional devices for comprehensive monitoring
Dependent on integration partners for full functionality
May require frequent replacement
Starting price: —
Product similarity: 75% VitalPatch supports continuous monitoring of post-surgical patients recovering at home, sharing the target audience of post-operative patients requiring ongoing health management. Its role in remote recovery monitoring complements the type of adherence tracking central to the user's dietary intervention program.
Customer feedback: 4.2/5
Pros
Established pharmaceutical company
Strong presence in pain management
Research-backed solutions
Cons
Limited behavioral intervention focus
May not address dietary adherence specifically
Starting price: —
Product similarity: 70% Eli Lilly's postoperative care solutions target the same post-surgical recovery phase as the user's program, addressing patient management after surgical procedures. Both operate in the post-operative care space, though the user's project focuses specifically on dietary behavior change rather than pharmaceutical management.
Customer feedback: <UNKNOWN>
1-10 of 20 competitors